Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$67.31 - $124.76 $1.48 Million - $2.74 Million
22,000 New
22,000 $2.12 Million
Q3 2022

Nov 14, 2022

BUY
$75.71 - $119.24 $2.2 Million - $3.47 Million
29,100 New
29,100 $3.22 Million
Q2 2021

Aug 16, 2021

SELL
$69.38 - $86.75 $215,078 - $268,925
-3,100 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$72.25 - $168.95 $1.42 Million - $3.31 Million
-19,600 Reduced 86.34%
3,100 $230,000
Q4 2020

Feb 16, 2021

SELL
$125.56 - $178.74 $251,120 - $357,480
-2,000 Reduced 8.1%
22,700 $3.87 Million
Q3 2020

Nov 16, 2020

SELL
$127.12 - $172.34 $927,976 - $1.26 Million
-7,300 Reduced 22.81%
24,700 $3.47 Million
Q2 2020

Aug 14, 2020

BUY
$93.0 - $171.7 $2.41 Million - $4.45 Million
25,900 Added 424.59%
32,000 $5.13 Million
Q1 2020

May 15, 2020

SELL
$82.38 - $131.64 $2.89 Million - $4.62 Million
-35,100 Reduced 85.19%
6,100 $598,000
Q4 2019

Feb 14, 2020

BUY
$76.53 - $135.58 $1.32 Million - $2.35 Million
17,300 Added 72.38%
41,200 $5.32 Million
Q3 2019

Nov 14, 2019

BUY
$72.81 - $156.91 $1.2 Million - $2.59 Million
16,500 Added 222.97%
23,900 $1.8 Million
Q2 2019

Aug 14, 2019

SELL
$112.21 - $151.95 $864,017 - $1.17 Million
-7,700 Reduced 50.99%
7,400 $1.12 Million
Q1 2019

May 15, 2019

BUY
$106.67 - $151.68 $1.61 Million - $2.29 Million
15,100 New
15,100 $1.8 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Css LLC Portfolio

Follow Css LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.